spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


Right arrow Help viewing high resolution images
Right arrow Return to article
(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.



Fig. 6. Regulation of the ATH5 promoter during retinogenesis. (A) Retinal cells isolated at stages 22 (E3) to 37 (E12) were transfected with an ATH5-promoter/CAT-reporter plasmid singly or in combinations with ATH5 and/or NGN2 expression vectors. Cells were assayed for CAT activity 24 hours after transfection. ATH5 transcription is passing through three phases in the course of retinogenesis. During the first phase (HH22-HH24), the promoter is weakly active and responds strongly to NGN2 overexpression, except in the presence of ATH5. During the second phase (HH25-HH30), upregulation of promoter activity coincides with a transient increase in ATH5 mRNA (curve). ATH5 and NGN2 both enhance promoter activity and ATH5 becomes dominant over NGN2. The third phase (HH34 and beyond) sees a decrease in ATH5 mRNA and is marked by the inability of either proneural protein to transactivate the promoter. (B) Retinal cells isolated at stages 22-23 and 29-30 were transfected with an ATH5-promoter/lacZ-reporter plasmid singly or in combinations with NGN2 or ATH5 expression vectors. lac+ cells were counted after 24 hours in culture. The number of lac+ cells obtained upon transfection with a control SV40-promoter/lacZ-reporter plasmid at each stage is set at 100 and cell numbers are given relative to this value. (C) Schematic representation of promoter activity as revealed by X-gal and CAT assays. Approximately 30% of cells express ATH5 at stages 22-23 and 29-30. The horizontal arrows indicate average promoter activity as measured by CAT assay, the open arrowhead marks the threshold for X-gal detection. At stage 22-23, promoter activity is low and only one in 30 ATH5-expressing cells is detected by X-gal. Overexpression of NGN2 increases promoter activity 10-fold but only six out of 30 ATH5-expressing cells are stained with X-gal. At stage 29-30, the whole population of ATH5-expressing cells is stained with X-GAL upon ATH5 overexpression. (D) At stage 22-23, most cells are weakly stained with X-GAL (arrowheads in a). Overexpression of NGN2 strongly enhances promoter activity (b) and the number of X-gal stained cells. At stage 29-30, cells display strong promoter activity (c) and overexpression of ATH5 enhances staining intensity (d).





Right arrow Return to article